Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Haemato-Oncology
- Brain and Spinal Cord Cancer
- Paediatric Cancers
- Gynecological Cancers
- Endometrial Cancer
- Cervical Cancer
- Pancreatic Cancer
- Chemoprevention
Abstract
Citation: Clin Oncol. 2017;2(1):1366.DOI: 10.25107/2474-1663.1366
Addressing the Challenges of HIV/AIDS-Defining Non- Hodgkin’s Lymphomas in Sub-Saharan Africa
Shaheen Mowla
Department of Pathology, Faculty of Health Sciences, University of Cape Town, South Africa
*Correspondance to: Shaheen Mowla
PDF Full Text Review Article | Open Access
Abstract:
Southern Africa has the highest HIV incidence worldwide. Thus far there is no cure; however, the lives of individuals infected with the virus can be prolonged through the use of Highly Active AntiRetroviral Therapy (HAART). According to the United Nations Programme on HIV and AIDS (UNAIDS) fact sheet for 2015, 2 out of 3 new HIV infections are in the Sub-Saharan African region, with approximately 25.8 million people living with HIV and 1.4 million new infections in 2014. In 2004, South Africa introduced ART (Anti-retroviral Therapy) free of charge in the public healthcare sector, and today South Africa has the largest treatment programme in the world - approximately 2.4 million people have received the life-saving treatment which has significantly increased their life expectancy.
Keywords:
Cite the Article:
Mowla S. Addressing the Challenges of HIV/AIDS-Defining Non-Hodgkin’s Lymphomas in Sub-Saharan Africa. Clin Oncol. 2017; 2: 1366.
